Open access
Oct 2026
Lipoprotein(a) and extent of coronary artery disease in patients undergoing PCI
Lipoprotein(a) [Lp(a)] has emerged as an independent contributor to residual atherosclerotic cardiovascular risk. However, its association with angiographic disease burden among patients undergoing percutaneous coronary intervention (PCI) remains incompletely characterized. To evaluate the relationship bet...
P. Theofilis, P. Vlachakis, A. Papanikolaou et al.
· European Heart Journal · 0 citations